HCAT Stock Analysis: Buy, Sell, or Hold?
HCAT - Health Catalyst, Inc Common Stock
$2.08
0.01 (0.48%)
▲
5d:
+17.51%
30d:
+54.07%
90d:
+79.31%
HOLD
MODERATE Confidence
Analysis Updated: Jul 2, 2026 12:00 AM ET
Earnings: Aug 06, 2026
Get Alerted When HCAT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD - EXTENDED: HCAT is 8.3% above its trading range ($1.92). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
📊 HOLD - EXTENDED: HCAT is 8.3% above its trading range ($1.92). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
In-depth Analysis How we analyze
Valuation Analysis: HCAT is currently trading at $2.08, which is considered extended relative to its 30-day fair value range of $1.45 to $1.92. From a valuation perspective, the stock is trading at a premium (Forward PE: 22.5) compared to its historical average (9.1). At these levels, the market is pricing in 35.5% annual earnings growth. This is a high bar to clear, indicating the stock may be priced for perfection.
Technical Outlook: Technically, HCAT is in a strong downtrend. Immediate support is located at $1.24, while resistance sits at $2.23.
Market Sentiment: HCAT has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, HCAT is in a strong downtrend. Immediate support is located at $1.24, while resistance sits at $2.23.
Market Sentiment: HCAT has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$1.45 -
$1.92
Company Quality Score
57/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
45.2%
Protect Your Profits
HCAT is technically overbought (RSI 71). Consider hedging now to protect against a potential pullback while keeping your upside.
View Profit Protection PlanAll Signals
- BEARISH: Price extended above range (+8.3% above its trading range)
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BEARISH: Trading above Wall St target ($1.90)
- BEARISH: Market expects 35.5% growth - appears too optimistic based on history
Trading Range Analysis
30-Day Trading Range
$1.45 -
$1.92
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$1.24
Resistance Level
$2.23
Current Trend
Strong Downtrend
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
22.54
Wall Street Target
$1.90
(-8.7%)
Revenue Growth (YoY)
-10.9%
Profit Margin
-87.7%
Valuation Premium vs History
+35.5% premium
PE vs Historical
22.5 vs 9.1
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+35.5%
(market-implied from PE analysis)
1-Year Target
$2.82
(+36%)
2-Year Target
$3.82
(+84%)
3-Year Target
$5.17
(+149%)
3-Yr Target (if PE normalizes)
(PE: 23→9)
PE COMPRESSION
$2.09
(+1%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 22.5, Growth: 119.8%)
$7.02
(+238%)
Base:
(SPY PE: 21.8, Growth: 119.8%)
$6.78
(+226%)
Bear:
(PE: 9.1, Growth: 119.8%)
$2.83
(+36%)
Share & Embed Analysis
Last updated: July 02, 2026 10:38 PM ET
Data refreshes hourly during market hours. Next update: 11:38 PM
Data refreshes hourly during market hours. Next update: 11:38 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is HCAT showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Health Information Services Stocks
Top-rated stocks in Health Information Services by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
VEEV
Veeva Systems Inc Class A |
BUY
32 analysts |
$245 | 61 BUY |
|
PRVA
Privia Health Group Inc |
STRONG BUY
21 analysts |
$31 | 54 HOLD |
|
GEHC
GE HealthCare Technologi… |
STRONG BUY
21 analysts |
$90 | 65 BUY |
|
PHR
Phreesia Inc |
STRONG BUY
15 analysts |
$14 | 66 BUY |
|
EVH
Evolent Health Inc |
STRONG BUY
14 analysts |
$6 | 63 BUY |
Advanced HCAT Option Strategies
Professional options setups generated by AI based on today's HCAT price and gamma walls.
